PFO
NTUS

Pathstone Family Office’s Natus Medical Inc NTUS Stock Holding History

Pathstone Family Office’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,910
Closed -$101K – 1384
2020
Q3 		$101K Buy
+5,910
New +$112K 0.01% 281

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pathstone Family Office's NTUS Position: Q4 2020 in Review

Pathstone Family Office sold out of Natus Medical Inc (NTUS) in Q4 2020, closing a stake of 5,910 shares — an estimated $101K sold.

Pathstone Family Office first reported a position in NTUS in Q3 2020 and held it in 1 quarter. The position peaked at $101K in Q3 2020. 163 funds tracked by Wall St. Rank hold NTUS as of Q4 2020.

  • Pathstone Family Office reported no remaining Natus Medical Inc position as of Q4 2020 after selling out during the quarter.
  • Pathstone Family Office sold 5,910 Natus Medical Inc shares in Q4 2020, an estimated $101K.
  • Pathstone Family Office first reported a position in Natus Medical Inc in Q3 2020 and held it in 1 quarter.
  • Pathstone Family Office's Natus Medical Inc position peaked at $101K in Q3 2020.
  • 163 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2020.

Based on Pathstone Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.